Acetazolamide attenuates chemical-stimulated but not thermal-stimulated acute pain in mice
- PMID: 24335844
- PMCID: PMC4075747
- DOI: 10.1038/aps.2013.149
Acetazolamide attenuates chemical-stimulated but not thermal-stimulated acute pain in mice
Abstract
Aim: Acetazolamide (AZA), a carbonic anhydrase (CA) inhibitor, has been found to alleviate inflammatory and neuropathic pain in rats. In the present study, we investigated the effects of AZA on thermal- and chemical-stimulated acute pain in mice and the possible mechanisms underlying the effects.
Methods: Five acute pain models based on thermal and chemical stimuli were established to investigate the effects of AZA on different types of nociception in mice. The antinociceptive effects of methazolamide (another CA inhibitor) and diazepam (a positive allosteric modulator of GABAA receptor) were also examined. The drugs were administered either intraperitoneally (ip) or intrathecally.
Results: AZA (50-200 mg/kg, ip) did not produce analgesia in two thermal-stimulated acute pain models, ie, mouse tail-flick and hot-plate tests. In contrast, AZA (50-200 mg/kg, ip) dose-dependently reduced paw licking time in both capsaicin and formalin tests in mice. A similar result was observed in a mouse acetic acid-induced writhing test. However, AZA (10 nmol/mouse, intrathecally) did not produce significant analgesia in the 3 chemical-stimulated acute pain models. In addition, methazolamide (50-200 mg/kg, ip) and diazepam (0.25-1.0 mg/kg, ip) did not produce significant analgesia in either thermal- or chemical-stimulated acute pain.
Conclusion: AZA produces analgesia in chemical-stimulated, but not thermal-stimulated acute pain in mice. The attenuation of chemical-stimulated acute pain by AZA may not be due to enhancement of GABAA receptor-mediated inhibition via inhibiting CA activity but rather a peripheral ion channel-related mechanism.
Figures





Similar articles
-
Inhibition of carbonic anhydrase augments GABAA receptor-mediated analgesia via a spinal mechanism of action.J Pain. 2014 Apr;15(4):395-406. doi: 10.1016/j.jpain.2014.01.001. Epub 2014 Jan 9. J Pain. 2014. PMID: 24412803 Free PMC article.
-
Acetazolamide, a carbonic anhydrase inhibitor, reverses inflammation-induced thermal hyperalgesia in rats.J Pharmacol Exp Ther. 2005 May;313(2):921-7. doi: 10.1124/jpet.104.082776. Epub 2005 Mar 2. J Pharmacol Exp Ther. 2005. PMID: 15743922
-
The antinociceptive effect of SNAP5114, a gamma-aminobutyric acid transporter-3 inhibitor, in rat experimental pain models.Anesth Analg. 2013 May;116(5):1162-1169. doi: 10.1213/ANE.0b013e318282dda7. Epub 2013 Mar 1. Anesth Analg. 2013. PMID: 23456665
-
Acetazolamide for the treatment of idiopathic intracranial hypertension.Expert Rev Neurother. 2015;15(8):851-6. doi: 10.1586/14737175.2015.1066675. Epub 2015 Jul 7. Expert Rev Neurother. 2015. PMID: 26154918 Review.
-
Carbonic anhydrase inhibition and the management of neuropathic pain.Expert Rev Neurother. 2016 Aug;16(8):961-8. doi: 10.1080/14737175.2016.1193009. Epub 2016 Jun 2. Expert Rev Neurother. 2016. PMID: 27211329 Review.
Cited by
-
Carbonic Anhydrase Activators for Neurodegeneration: An Overview.Molecules. 2022 Apr 14;27(8):2544. doi: 10.3390/molecules27082544. Molecules. 2022. PMID: 35458743 Free PMC article. Review.
-
Comparison of intraperitoneal bupivacaine, acetazolamide, and placebo on pain relief after laparoscopic cholecystectomy surgery: A clinical trial.Med J Islam Repub Iran. 2018 Nov 13;32:112. doi: 10.14196/mjiri.32.112. eCollection 2018. Med J Islam Repub Iran. 2018. PMID: 30815407 Free PMC article.
-
Developmental loss, but not pharmacological suppression, of renal carbonic anhydrase 2 results in pyelonephritis susceptibility.Am J Physiol Renal Physiol. 2020 Jun 1;318(6):F1441-F1453. doi: 10.1152/ajprenal.00583.2019. Epub 2020 May 11. Am J Physiol Renal Physiol. 2020. PMID: 32390512 Free PMC article.
-
Acetazolamide reduces postoperative pain following laparoscopic inguinal herniorrhaphy.Surg Endosc. 2016 Jul;30(7):2685-9. doi: 10.1007/s00464-015-4564-4. Epub 2015 Oct 20. Surg Endosc. 2016. PMID: 26487218
References
-
- Moore ND. In search of an ideal analgesic for common acute pain. Acute Pain. 2009;11:129–37.
-
- Kaur IP, Smitha R, Aggarwal D, Kapil M. Acetazolamide: future perspective in topical glaucoma therapeutics. Int J Pharm. 2002;248:1–14. - PubMed
-
- Velázquez H, Wright FS. Control by drugs of renal potassium handling. Annu Rev Pharmacol Toxicol. 1986;26:293–309. - PubMed
-
- Kassamali R, Sica DA. Acetazolamide a forgotten diuretic agent. Cardiol Rev. 2011;19:276–8. - PubMed
-
- Aaslid R. Cerebral autoregulation and vasomotor reactivity. Front Neurol Neurosci. 2006;21:216–28. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources